Global Submucosal Injections Market size is expected to be worth around US$ 4.0 Billion by 2034 from US$ 2.3 Billion in 2024.
St. Luke’s Medical Center – Global City’s Institute of Digestive and Liver Diseases (IDLD) has officially been designated a ...
PRV111, a nanoengineered, cisplatin-releasing transmucosal patch, achieved a 95.5% pathologic complete response (pCR) rate in patients with non-invasive oral cancer or high-grade dysplasia (HGD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results